United States · FDA National Drug Code directory

Marcaine

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
0409-2253_7040888c-2cde-4408-af99-d249985f8444
Product NDC
0409-2253
Form
INJECTION, SOLUTION
Composition / generic term
BUPIVACAINE HYDROCHLORIDE
Labeler
Hospira, Inc.
Marketing category
NDA
Marketing start / end (source format)
20250414
Source listing expiry
20271231

Source-listed ingredients

  • BUPIVACAINE HYDROCHLORIDE — 225 mg/30mL

These values do not establish equivalence or a dose recommendation.

Packages

  • 25 VIAL, SINGLE-DOSE in 1 TRAY (0409-2253-25) / 30 mL in 1 VIAL, SINGLE-DOSE (0409-2253-01) · 0409-2253-25

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →